Project Grant R01HL176283
Award Date
8/15/24
Completion Date
6/30/29
Dollars Obligated
$1.9M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This $565,250 federal Project Grant award was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports a 5-year longitudinal study led by Duke University to characterize the effects of host-microbiome interactions on pulmonary function in a cohort of 500 adults with and without HIV in Botswana. The study will utilize advanced multi-omics techniques, including shotgun metagenomic sequencing, host...
This federal Project Grant award of $1,405,336 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to investigate the pathophysiological mechanisms by which HIV and cigarette smoke exposure lead to chronic obstructive pulmonary disease (COPD) in people living with HIV. The key aims of the research are to: 1) Identify how HIV Tat protein and cigarette smoke exposure alter the microRNA landscape to suppress the IRS-1/ADAM17 pathway,...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $759,983.00 to the University of North Carolina at Chapel Hill to investigate neutrophil function and the lung microenvironment during Streptococcus pneumoniae pneumonia and acute lung injury. The study aims to determine how neutrophils change as they are recruited and function during pneumonia, compare neutrophils defined by specific criteria, and examine changes...
This Project Grant award of $915,924 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to investigate how disruptions to early-life microbial colonization of the lungs, such as through antibiotic use, can lead to chronic respiratory diseases by remodeling the developmental pathways of lung-resident immune cells and epithelial cells. The research aims to define the specific microbial taxa essential for establishing lung homeostasis...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $1,485,606 in funding to The Johns Hopkins University to conduct a comprehensive research project titled "Lipoprotein (A) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease". The project aims to identify lipoprotein(a) risk thresholds, explore mechanisms linking lipoprotein(a) to heightened cardiovascular disease risk...
This $749,228 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports collaborative research to investigate the linkages between HIV/STI prevention and syndemic behaviors in high-risk youth. The principal investigators will harmonize data from 6 prior youth HIV/STI and syndemic prevention intervention studies to use advanced machine learning methods to examine the role of youth-provider relationships in intervention outcomes....
This Project Grant award of $793,247 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to develop and implement a data-driven algorithm for assigning validated causes of hospitalizations among people with HIV, estimate trends in cause-specific hospitalization rates, and develop a hospitalization risk score for use in outpatient HIV care. The award date is November 12, 2024, with...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $148,824 to the Research Foundation of the City University of New York (RFCUNY) over a 5-year period from August 2024 to July 2029. The goal of the research is to understand the clinical and social factors that impact HIV and COVID-19 outcomes among people with HIV (PWH), and to characterize how the COVID-19...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to The Administrators of Tulane Educational Fund, doing business as Tulane University, will support research to understand the role of CD4+ T cells in respiratory tract immunity and defense against pathogens, particularly in the context of pneumonia. The $1,063,324 award from June 2025 to May 2032 will enable the research team to assess the metabolic requirements and...
This federal Project Grant award of $249,000.00 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to investigate mechanisms that enhance and suppress HIV-1 resistance in gene-edited primary human cells. The award aims to study the interactions between T cells, TRIM proteins, and HIV-1 virus that influence viral replication, with the goal of developing an improved therapeutic platform for genetically modified autologous hematopoietic...